Menlo Park investment firm Sofinnova Ventures has raised $440 million for its Sofinnova Venture Partners VIII. It is looking to invest in later-stage healthcare companies in the U.S. and in foreign countries, and is primarily eying European markets.
The firm will primarily target clinical-stage drug development and offshoots. The fund’s partners include Jim Healy, Garheng Kong, Mike Powell, Anand Mehra, Lars Ekman and David Kabakoff.
Click here for the release from Sofinnova.
Sofinnova Ventures Sofinnova Venture Partners Menlo Park Lars Ekman Anand Mehra